COPD overlooked in cardiovascular patients

By Laura Cowen, medwireNews Reporter

More than a quarter of patients with cardiovascular disease (CVD) and a history of smoking also have air flow limitation compatible with chronic obstructive pulmonary disease (COPD), Japanese study data show.

Strikingly, the vast majority (87.7%) of patients found to have such airflow limitation had not previously been diagnosed with COPD, report Katsuya Onishi (Onishi Heart Clinic, Mie) and colleagues.

“This suggests that it is important to look routinely for COPD in CVD patients >40 years old with a history of smoking, as the combination of COPD with CVD is known to be associated with poorer prognosis”, they remark.

The researchers prospectively measured forced expiratory volume in 1 second (FEV1) and in 6 seconds (FEV6) by handheld spirometry in 995 consecutive outpatients (mean age 66.6 years, 95.5% men) with a smoking history who routinely visited one of 17 CVD clinics in Japan. The 269 patients with a FEV1/ FEV6 ratio less than 0.73 were classed as having airflow limitation compatible with COPD.

These patients were, on average, significantly older than patients without airflow limitation (71 vs 65 years), had a significantly lower mean body mass index (23.3 vs 25.1 kg/m2), and were more likely to have chronic bronchitis symptoms (25.3 vs 18.6%) and a higher COPD assessment test score (8.3 vs 6.4).

Although the prevalence of COPD increased with age (up to 39% in those aged 70 years and older) and was more likely to have previously been diagnosed in older patients (13.8% of those aged 70 years and older), cases still occurred in younger patients, with a rate of 5.1% observed in those aged 40 to 49 years, none of whom had been previously diagnosed.

As expected, the percentage of patients with a prior diagnosis of COPD increased with increasing spirometry use, but still only reached 14.0% in centres classed as using spirometry “often” (≥10 times/month), compared with 11.1% in those that seldom used it (<2 times/month).

The researchers also point out that around 20% of the patients they studied had lung function less than 50% of the Global initiative for chronic Obstructive Lung Disease FEV1 predicted values. This shows that even patients with severe to very severe airflow limitation had not previously been diagnosed with COPD, they say.

The study findings are published in the International Journal of Chronic Obstructive Pulmonary Disease.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover immune mechanism behind myocarditis from cancer immunotherapy